Status:
COMPLETED
Comparison of I-gel to the Laryngeal Mask Airway
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Endotracheal Intubation
Supraglottic Airway
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate a new disposable supra-glottic airway device, the i-gel airway (Intersurgical Ltd., Wokingham, England). We propose to test its ease of insertion, position wit...
Detailed Description
During the past decade, several pharyngeal airways have been introduced for airway management, such as the Laryngeal Mask Airway (LMA), the Cobra perilaryngeal airway, the Esophageal Tracheal Combitub...
Eligibility Criteria
Inclusion
- The subjects will be adult surgical candidates aged 18-80, ASA I-II, Mallampati I or II, presenting for elective surgery who require general anesthesia in whom tracheal intubation is not necessary.
- Both male and female patients will be included.
Exclusion
- Patients will be excluded from the study if they present as Mallampati III or IV, ASA III-V or emergency status. Additionally, they will be excluded if they meet one of the contraindication criteria of the LMA including:
- obesity, (BMI \> 35 kg/m2)
- pregnancy
- history of gastric regurgitation, heart burn, ileus or "full stomach"
- history of low pulmonary compliance or high pulmonary resistance
- known history of difficult endotracheal intubation or signs suggesting the possibility of difficult intubation
- pharyngeal pathology
- upper airway obstruction due to laryngeal pathology
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00706823
Start Date
February 1 2008
End Date
August 1 2008
Last Update
February 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Hermann Hospital
Houston, Texas, United States, 77030